Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
BMJ Group
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595980/ |